143 related articles for article (PubMed ID: 32311432)
1. The treatment of recurrent conjunctival and corneal intraepithelial neoplasia with interferon alfa-2b and retinoic acid: ~9 years' follow-up on tumor control.
Ip MH; Tat L; Coroneo MT
Ocul Surf; 2020 Jul; 18(3):354-359. PubMed ID: 32311432
[TBL] [Abstract][Full Text] [Related]
2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
Schechter BA; Koreishi AF; Karp CL; Feuer W
Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
[TBL] [Abstract][Full Text] [Related]
6. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
Vann RR; Karp CL
Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
[TBL] [Abstract][Full Text] [Related]
7. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
[TBL] [Abstract][Full Text] [Related]
8. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
[TBL] [Abstract][Full Text] [Related]
9. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
Di Pascuale MA; Espana EM; Tseng SC
Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965
[TBL] [Abstract][Full Text] [Related]
10. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
[TBL] [Abstract][Full Text] [Related]
11. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Karp CL; Moore JK; Rosa RH
Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
Shousha MA; Karp CL; Perez VL; Hoffmann R; Ventura R; Chang V; Dubovy SR; Wang J
Ophthalmology; 2011 Aug; 118(8):1531-7. PubMed ID: 21507486
[TBL] [Abstract][Full Text] [Related]
13. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
Finger PT; Sedeek RW; Chin KJ
Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
[TBL] [Abstract][Full Text] [Related]
14. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia.
Pagán Carrasco S; Arranz Maestro D
Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536
[TBL] [Abstract][Full Text] [Related]
15. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
[TBL] [Abstract][Full Text] [Related]
18. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
19. [Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia].
Toledano Fernández N; García Sáenz S; Díaz Valle D; Arteaga Sánchez A; Segura Bedmar M; Lorenzo Giménez S; Cortés Lambea L
Arch Soc Esp Oftalmol; 2003 May; 78(5):265-71. PubMed ID: 12789630
[TBL] [Abstract][Full Text] [Related]
20. Treatment of CIN with retinoic acid and topical interferon alfa-2b.
Huerva V
Ophthalmology; 2013 Aug; 120(8):e55. PubMed ID: 23916085
[No Abstract] [Full Text] [Related]
[Next] [New Search]